United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

4:26am EDT
Change (% chg)

€-0.05 (-0.20%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for GRLS.MC


Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)


Beta: 0.32
Market Cap(Mil.): €15,633.00
Shares Outstanding(Mil.): 687.55
Dividend: 0.18
Yield (%): 1.25


  GRLS.MC Industry Sector
P/E (TTM): 31.29 14.29 17.36
EPS (TTM): 0.80 -- --
ROI: 6.19 -7.57 -5.72
ROE: 15.55 -7.17 -5.10

BRIEF-Grifols Q1 net profit up 7 pct YoY

* Q1 net profit 134.0 million euros ($146.3 million) versus 125.2 million euros year ago

May 03 2017

BRIEF-Reig Jofre to produce biotech vaccine for Laboratorios Leti

* To produce for Laboratorios Leti biotech vaccine developed from protein Q, which Laboratorios Leti plans to commercialize internationally

May 03 2017

Spanish stocks - Factors to watch on Tuesday

The following Spanish stocks may be affected by newspaper reports and other factors on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

Apr 25 2017

BRIEF-Grifols says restated its 2005 agreement with Orasure Technologies

* Grifols - announces that it has restated its 2005 agreement with Orasure Technologies

Apr 24 2017

BRIEF-Grifols closes 1.00 bln euro bond issue, completes debt refinance process

* Says closes 1.00 billion euro ($1.07 billion)issue of senior unsecured bonds due May 1st 2025, with annual coupon of 3,20 percent

Apr 18 2017

BRIEF-Grifols launches repurchase offer for senior notes due 2022 for $1.00 bln

* Says its unit, Grifols Worldwide Operations Limited, has launched repurchase offer for senior notes due 2022 for $1.00 billion Source text for Eikon:

Apr 06 2017

BRIEF-Grifols unit intends to redeem notes due 2022

* Its unit, Grifols Worldwide Operations Limited, intends to redeem the notes due 2022

Mar 20 2017

BRIEF-Grifols FY EBITDA down 1.8 pct YoY

* FY net profit 545.5 million euros ($577.3 million) versus 553.2 million euros in Reuters poll

Feb 28 2017

BRIEF-Spain's Grifols says has concluded debt refinancing for $6.3 bln

* Says it has concluded the debt refinancing process it started on Jan. 9 and has refinanced debt for $6.3 billion

Feb 06 2017

BRIEF-Grifols buys 49 pct in US-based Access Biologicals for $51 million

* Invests in US-based Access Biologicals via acquisition of 49 percent of its voting rights for $51 million

Jan 12 2017

More From Around the Web

Earnings vs. Estimates